コンパニオンアニマル・ワクチン市場：製品タイプ、動物タイプ、流通チャネル別-2025-2030年世界予測

コンパニオンアニマル・ワクチン市場は、2023年に46億1,000万米ドルと評価され、2024年には49億7,000万米ドルに達すると予測され、CAGR 8.18%で成長し、2030年には80億1,000万米ドルに達すると予測されています。

コンパニオンアニマル・ワクチン市場は、犬、猫、鳥、ウサギなどのペットを感染症から守るための予防接種ソリューションに焦点を当てた、より大きな獣医学分野の中のダイナミックなセグメントです。ワクチンは、伝染病の発生を予防し、動物の福祉を確保する上で極めて重要であり、最終的には動物と動物に接する人間双方の生活の質を向上させる。市場の用途は、動物病院、病院、ペットの飼い主向けに設計された単一ワクチンから多価ソリューションまで多岐にわたる。ペットの健康に対する意識の高まりと相まって、ペットの飼育が増加していることが市場成長の原動力となっています。さらに、DNAワクチンや組み換えベクターワクチンのようなワクチン開発における技術的進歩は、技術革新に有利な機会を提供しています。成長に影響を与える重要な要因として、規制当局による特定のワクチン接種の強制があり、これらの製品の必要性が強調されています。しかし、研究開発コストの高さや、新規参入企業の迅速な市場参入を阻害しかねない厳しい規制当局の承認などの課題もあります。さらに、ホリスティック・ケアや代替医療を求めるペットの動向の高まりは、ワクチン接種の普及と相反する場合があります。地域的には、可処分所得の増加とペットケアの基準の変化により、新興市場に潜在的な成長機会があります。企業は、地域に特化した研究に投資し、地域に特化した戦略を開発することで、こうした機会を活用することができます。事業成長につながる技術革新の分野には、経口ワクチンのような新規デリバリーシステムの研究や、既存ワクチンの有効期間延長などがあります。また、動物の遺伝子プロファイリングに基づいてカスタマイズされたワクチンソリューションに取り組むことも重要です。課題はあるもの、ペットの健康に対する市場の積極的な姿勢は、研究開発が重要な役割を果たすことで、大きな成長の道を提供し続けています。利害関係者は、潜在的な市場浸透と持続可能性を最大化するために、規制状況をナビゲートし、教育と啓蒙活動に投資しなければならないです。

市場力学：急速に進化するコンパニオンアニマル・ワクチン市場の主要市場インサイトを公開

コンパニオンアニマル・ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルの世界の普及
  • コンパニオンアニマル疾患の有病率の増加
  • 動物の健康と福祉に対する消費者の支出の増加
• 市場抑制要因
  • ワクチンの高コストと政府の不利な枠組み
• 市場機会
  • 継続的なワクチン接種の推進と動物福祉のための組織的努力
  • ペット保険の利用可能性とペット保険サービスプロバイダーの普及
• 市場の課題
  • 動物ワクチン接種による悪影響

ポーターの5つの力：コンパニオンアニマル・ワクチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コンパニオンアニマル・ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、コンパニオンアニマル・ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コンパニオンアニマル・ワクチン市場における競合情勢の把握

コンパニオンアニマル・ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコンパニオンアニマル・ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コンパニオンアニマル・ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コンパニオンアニマル・ワクチン市場における成功への道筋を描く

コンパニオンアニマル・ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でペットの飼育が増加
    • ペットの病気の増加
    • 動物の健康と福祉に対する消費者支出の増加
  • 抑制要因
    • ワクチンの高コストと不利な政府の枠組み
  • 機会
    • 継続的なワクチン接種活動と動物福祉のための組織的取り組み
    • ペット保険の入手可能性とペット保険サービス提供者の普及率
  • 課題
    • 動物ワクチン接種の悪影響
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コンパニオンアニマル・ワクチン市場：製品タイプ別

• 弱毒生ワクチン
• 結合ワクチン
• DNAワクチン
• 不活化ワクチン
• 組み換えワクチン
• サブユニットワクチン
• トキソイドワクチン

第7章 コンパニオンアニマル・ワクチン市場動物の種類別

• 犬
• 馬
• ネコ科

第8章 コンパニオンアニマル・ワクチン市場：流通チャネル別

• 獣医クリニック
• 動物病院
• 獣医調査機関

第9章 南北アメリカのコンパニオンアニマル・ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のコンパニオンアニマル・ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのコンパニオンアニマル・ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biogenesis Bago
• Biovet Private Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Elanco Animal Health
• Hester Biosciences Limited
• Hipra Laboratories, S.A.
• ImmuCell Corporation
• Merck & Co.
• Neogen Corporation
• Novartis AG
• Ourofino Animal Health
• Phibro Animal Health Corporation
• Sanofi S.A.
• Virbac Group

LIST OF FIGURES

• FIGURE 1. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
• FIGURE 2. COMPANION ANIMAL VACCINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMPANION ANIMAL VACCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COMPANION ANIMAL VACCINE MARKET DYNAMICS
• TABLE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ATTENUATED LIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

The Companion Animal Vaccine Market was valued at USD 4.61 billion in 2023, expected to reach USD 4.97 billion in 2024, and is projected to grow at a CAGR of 8.18%, to USD 8.01 billion by 2030.

The companion animal vaccine market is a dynamic segment within the larger veterinary medicine field, focusing on immunization solutions to safeguard pets like dogs, cats, birds, and rabbits from infectious diseases. Vaccines are crucial in preventing outbreaks and ensuring animal welfare, ultimately enhancing the quality of life for both animals and humans who interact with them. The market applications range from single vaccines to multivalent solutions, designed for veterinary clinics, hospitals, and pet owners. Increasing pet ownership, coupled with rising awareness about pet health, is driving market growth. Additionally, technological advancements in vaccine development such as DNA vaccines and recombinant vector vaccines offer lucrative opportunities for innovation. A significant factor influencing growth is the compulsion for certain vaccinations by regulatory authorities, which underscores the necessity of these products. However, the market faces challenges, including high costs of R&D and stringent regulatory approvals which could inhibit rapid market entry for new players. Furthermore, a growing trend toward holistic and alternative pet health care can sometimes conflict with vaccination uptake. Geographically, emerging markets present potential growth opportunities due to increasing disposable incomes and changing pet care standards. Companies can capitalize on these opportunities by investing in localized research and developing region-specific strategies. Areas of innovation conducive to business growth include exploring novel delivery systems such as oral vaccines and extending the efficacy duration of existing vaccines. It's also valuable to delve into customized vaccine solutions based on the genetic profiling of animals. Despite its challenges, the market's proactive stance on pet health continues to offer significant growth avenues, with research and development playing a crucial role. Stakeholders must navigate regulatory landscapes and invest in education and awareness initiatives to maximize potential market penetration and sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Vaccine Market

The Companion Animal Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of companion animals worldwide
  • Growing prevalence of companion animal disorders
  • Rising consumer expenditure for animal health and welfare
• Market Restraints
  • High costs of vaccines and unfavorable governmental frameworks
• Market Opportunities
  • Ongoing vaccination drives and organizational efforts for animal welfare
  • Availability of pet insurance and penetration of pet insurance service providers
• Market Challenges
  • Adverse impacts of animal vaccination

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Vaccine Market

A detailed market share analysis in the Companion Animal Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Companion Animal Vaccine Market

A strategic analysis of the Companion Animal Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago, Biovet Private Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Limited, Hipra Laboratories, S.A., ImmuCell Corporation, Merck & Co., Neogen Corporation, Novartis AG, Ourofino Animal Health, Phibro Animal Health Corporation, Sanofi S.A., and Virbac Group.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine, Inactivated Vaccine, Recombinant Vaccine, Subunit Vaccine, and Toxoid Vaccine.
• Based on Animal Type, market is studied across Canine, Equine, and Feline.
• Based on Distribution Channel, market is studied across Veterinary Clinics, Veterinary Hospitals, and Veterinary Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of companion animals worldwide
    • 5.1.1.2. Growing prevalence of companion animal disorders
    • 5.1.1.3. Rising consumer expenditure for animal health and welfare
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of vaccines and unfavorable governmental frameworks
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing vaccination drives and organizational efforts for animal welfare
    • 5.1.3.2. Availability of pet insurance and penetration of pet insurance service providers
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse impacts of animal vaccination
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Companion Animal Vaccine Market, by Product Type

• 6.1. Introduction
• 6.2. Attenuated Live Vaccine
• 6.3. Conjugate Vaccine
• 6.4. DNA Vaccine
• 6.5. Inactivated Vaccine
• 6.6. Recombinant Vaccine
• 6.7. Subunit Vaccine
• 6.8. Toxoid Vaccine

7. Companion Animal Vaccine Market, by Animal Type

• 7.1. Introduction
• 7.2. Canine
• 7.3. Equine
• 7.4. Feline

8. Companion Animal Vaccine Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Veterinary Clinics
• 8.3. Veterinary Hospitals
• 8.4. Veterinary Research Institutes

9. Americas Companion Animal Vaccine Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Companion Animal Vaccine Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Companion Animal Vaccine Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago
• 2. Biovet Private Ltd.
• 3. Boehringer Ingelheim International GmbH
• 4. Ceva Sante Animale
• 5. Elanco Animal Health
• 6. Hester Biosciences Limited
• 7. Hipra Laboratories, S.A.
• 8. ImmuCell Corporation
• 9. Merck & Co.
• 10. Neogen Corporation
• 11. Novartis AG
• 12. Ourofino Animal Health
• 13. Phibro Animal Health Corporation
• 14. Sanofi S.A.
• 15. Virbac Group